Wei Ding
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Aging top 5%
Papers in
-
- Circular RNAs in diseases 16
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 4
- Cell death mechanisms and regulation 3
- Glycosylation and Glycoproteins Research 2
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Co-authors
- Jianxun Wang (27 shared papers)Xiang Ao (15 shared papers)Ying Liu (12 shared papers)Wanpeng Yu (7 shared papers)Tao Xu (7 shared papers)Xiaoyu Ji (3 shared papers)Mengyang Li (9 shared papers)Yifei Wang (2 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)Redox Biology (2 papers)Journal of Molecular Medicine (2 papers)FEBS Journal (2 papers)Cancer Letters (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Ding
41 papers receiving 2.5k citations
Wei Ding's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 861
- Aging 70
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 485
- Geriatrics and Gerontology 39
Countries citing papers authored by Wei Ding
This map shows the geographic impact of Wei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ding more than expected).
Fields of papers citing papers by Wei Ding
This network shows the impact of papers produced by Wei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ding. The network helps show where Wei Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular mechanisms of ferroptosis and its role in cancer therapy Hit paper breakdown → | 2019 | 506 |
| 2 | Critical role of FOXO3a in carcinogenesis Hit paper breakdown → | 2018 | 372 |
| 3 | 2018 | 201 | |
| 4 | 2020 | 113 | |
| 5 | 2021 | 108 | |
| 6 | 2015 | 103 | |
| 7 | 2017 | 99 | |
| 8 | 2019 | 96 | |
| 9 | 2019 | 96 | |
| 10 | 2018 | 91 | |
| 11 | 2000 | 73 | |
| 12 | 2017 | 57 | |
| 13 | 2019 | 56 | |
| 14 | 2023 | 55 | |
| 15 | 2019 | 53 | |
| 16 | 2019 | 44 | |
| 17 | 2020 | 43 | |
| 18 | 2020 | 36 | |
| 19 | 2007 | 34 | |
| 20 | 2000 | 33 |
About Wei Ding
Wei Ding is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 41 papers that have together received 2.6k indexed citations. Recurring topics across this work include Circular RNAs in diseases (16 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (4 papers), Autophagy in Disease and Therapy (4 papers), Cell death mechanisms and regulation (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (861 citations), Aging (70 citations), Molecular Biology (1.7k citations), Pulmonary and Respiratory Medicine (485 citations) and Geriatrics and Gerontology (39 citations). Wei Ding has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jianxun Wang, Xiang Ao, Ying Liu, Wanpeng Yu, Tao Xu, Xiaoyu Ji, Mengyang Li, Yifei Wang, Peifeng Li and Xuejuan Zhang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Redox Biology, Journal of Molecular Medicine, FEBS Journal and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.